Notice to Extend the Response Date for NOT-CA-22-033 "Request for Information (RFI): Seeking Input from Multi-Cancer Early Detection Test Developers on Readiness for Participation in an NCI-Sponsored Clinical Utility Randomized Controlled Screening Trial
Notice Number:
NOT-CA-22-059

Key Dates

Release Date:

March 1, 2022

Related Announcements

NOT-CA-22-033 - Request for Information (RFI): Seeking Input from Multi-Cancer Early Detection Test Developers on Readiness for Participation in an NCI-Sponsored Clinical Utility Randomized Controlled Screening Trial

Issued by

National Cancer Institute (NCI)

Purpose

This Notice extends the response date for NOT-CA-22-033 "Request for Information (RFI): Seeking Input from Multi-Cancer Early Detection Test Developers on Readiness for Participation in an NCI-Sponsored Clinical Utility Randomized Controlled Screening Trial " to March 21, 2022.

The following sections of the NOT-CA-22-033 have been modified.

Key Dates

Currently reads:

Response Date: March 01, 2022

Modified to read (changes are shown below in bold italics):

Response Date: March 21, 2022

How to Submit a Response

Currently reads (first two lines):

Responses to this RFI must be submitted electronically to NCIMCED@nih.gov

Responses will be accepted through March 01, 2022.

Modified to read (changes are shown below in bold italics):

Responses to this RFI must be submitted electronically to NCIMCED@nih.gov

Responses will be accepted through March 21, 2022.

All other aspects of the RFI remain the same.

Inquiries

Please direct all inquiries to:

Christos Patriotis, Ph.D.,
National Cancer Institute (NCI)
Telephone: 240-276-7134
Email: patriotisc@mail.nih.gov